Winrevair (sotatercept-csrk), compared to placebo, reduced the risk of all-cause death, lung transplantation, and hospitalization.

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

By the secure transfer of data from EHRs to EDCs, the platform removes the necessity for manually entering the data.

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

Topline results were announced from a phase 3 trial evaluating Xyngari™ (formerly DMT310), a novel topical treatment derived ...

The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...

AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to ...

Through this partnership, NeOnc will initiate clinical trials across 30 FDA-compliant clinical research sites in India, increasing patient enrollment and accelerating development efforts for a novel ...